This 9%-yielding FTSE 250 dividend superstar looks like a hidden gem to me

FTSE 250 investment firm abrdn has fallen 32% in a year and was demoted from the FTSE 100. But now it looks very undervalued and pays a 9% yield.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Long-term vs short-term investing concept on a staircase

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

FTSE 250 global investment firm abrdn (LSE: ABDN) has had a terrible 12 months.

It was demoted from the FTSE 100 at the end of August 2023. This happened because the shares had fallen 15% in the year to that point, reducing its market capitalisation by 25%.

The relegation automatically triggered a wave of fresh selling from funds unable to hold non-FTSE 100 stocks.

And in a 24 January trading update, it said it is cutting 500 jobs to help reduce costs by £150m.

However, although I rarely buy stocks outside the FTSE 100 either, several things appeal to me about abrdn right now.

Serious ex-appeal

One of them is that this is not the first time abrdn has been relegated from the FTSE 100 to the FTSE 250. It happened a year before as well.

In the run-up to its previous demotion, its shares tumbled. They then crashed when the relegation announcement was made official in August 2022.

The company then cut some costs as it is doing now and added different revenue streams.

It was then promoted back to the FTSE 100 just four months later, and its shares spiked back up again.

Why might it be promoted again?

The current round of cost-cutting is deep and looks long overdue. According to the company, it will remove layers of management — always a good thing in my view.

It will also outsource more technology, which should not just reduce costs but increase operational efficiency, I think.

With overheads reduced, the company should be able to pump more money into its latest revenue generators.

Its 2022 acquisition of interactive investor was the key driver for abrdn’s 4% rise in operating revenue in H1 2023, for example.

The purchase of Tekla Capital Management’s healthcare funds also looks promising. US healthcare expenditure per capita has grown at a compound annual rate of 6% since the 1980s.

Consensus analyst expectations are now for abrdn’s earnings to rise by 89% a year until the end of 2026.

One risk in the stock is that this business reorganisation might fail. Another is that it might not be able to attract new net inflows into its funds.

Doubly undervalued against its peers

The automatic devaluation of abrdn after the FTSE 100 demotion, has left its shares undervalued on two key measures.

On a price-to-book ratio (P/B) basis, it trades at just 0.5 – the lowest in its peer group, the average P/B of which is 2.9.

The peer group comprises Caledonia Investments (at 0.6), Bridgepoint Group (2.7), St. James’s Place (2.8), and Hargreaves Lansdown (5.3).

On a price-to-sales ratio (P/S) basis, abrdn trades at 1.9 against a peer group average of 5.8. St. James’s Place is at 0.3, Hargreaves Lansdown at 5.1, Bridgepoint Group at 6.7, and Caledonia Investments at 10.9.

Therefore, on both measurements, abrdn is very undervalued relative to its peers.

I already hold several stocks in the financial sector, so buying more would unbalance my portfolio.

If I did not, I would probably buy abrdn now both for its growth potential and for its undervalued shares.

At least as appealing as these is its big yield – currently just over 9%. This is one of the very highest in either the FTSE 250 or FTSE 100.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Simon Watkins has no position in any of the shares mentioned. The Motley Fool UK has recommended Hargreaves Lansdown Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Google office headquarters
Investing Articles

1 reason I like buying S&P 500 shares – and 1 reason I don’t

Will this investor try to improve his potential returns by focusing more on S&P 500 shares instead of British ones?…

Read more »

Young woman holding up three fingers
Investing Articles

3 SIPP mistakes to avoid

Our writer explains a trio of potentially costly errors he tries to avoid making when investing his SIPP, on an…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

Here’s how (and why) I’d start buying shares with £25 a week

Our writer uses his investment experience and current approach to explain how he would start buying shares on a limited…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Here’s my 5-step approach to earning passive income of £500 a month

Christopher Ruane explains the handful of steps he uses to target hundreds of pounds in passive income each month.

Read more »

Investing Articles

2 UK shares I’ve been buying this week

From a value perspective, UK shares look attractive. But two in particular have been attracting Stephen Wright’s attention over the…

Read more »

Investing Articles

A lifelong second income for just £10 a week? Here’s how!

With a simple, structured approach to buying blue-chip dividend shares at attractive prices, our writer's building a second income for…

Read more »

Investing Articles

Here’s how I’d use a £20k Stocks and Shares ISA to help build generational wealth

Discover how our writer would aim to turn a £20k Stocks and Shares ISA into a sizeable nest egg by…

Read more »